Latest market price
21.80
+1.66+8.24%
KVYOQT40Klaviyo, Inc.·NYSE
21.80+8.24%
TA
Loading chart...
Screen all →
Snapshot
Index—P/E—EPS (ttm)0.02Insider Own—Shs Outstand299.28MPerf Week5.26%
Market Cap6.52BForward P/E20.82EPS next Y1.05Insider Trans-3.14%Shs Float254.83MPerf Month38.77%
Enterprise Value5.78BPEG55.95EPS next Q0.17Short Float7.91%Perf Quarter14.14%
Income7.00MP/S4.69EPS this Y27.26%Short Ratio3.31Perf Half Y-2.98%
Sales1.39BP/B6.75EPS next Y27.00%ROA0.49%Short Interest20.16MPerf YTD-32.86%
Book/sh3.23P/C7.83EPS next 5Y19.48%ROE0.61%52W High33.35 -34.63%Perf Year-14.07%
Cash/sh2.78P/FCF26.74EPS past 3/5Y—ROIC-1.51%52W Low12.53 73.98%Perf 3Y-19.41%
Dividend Est.—EV/EBITDA170.07Sales past 3/5Y37.66% —Gross Margin73.79%Volatility5.67% 5.40%Perf 5Y—
Dividend TTM—EV/Sales4.16EPS Y/Y TTM—Oper. Margin-1.86%ATR (14)1.06Perf 10Y—
Dividend Ex-Date—Quick Ratio3.13Sales Y/Y TTM28.94%Profit Margin0.49%RSI (14)68.82Recom2.18
Dividend Gr. 3/5Y—Current Ratio3.13EPS Q/Q18.75%SMA2015.35%Beta0.51Target Price26.57
Payout0.00%Debt/Eq0.09Sales Q/Q26.62%SMA5021.91%Rel Volume1.83Prev Close20.14
Employees2,400LT Debt/Eq0.09EarningsNov 04SMA20021.05%Avg Volume6.18MPrice21.80
IPO DateSep 20, 2023Option/ShortYes / YesEPS/Sales Surpr.-0.11% 2.35%Net Debt/EBITDA-21.82Volume11,300,377Change8.24%
Analyst Ratings
DateActionAnalystRatingTarget
Oct-16-26DowngradeGoldman SachsBuy → Neutral$26 → $20
Sep-10-26ReiteratedStifel Nicolaus$24 → $22
Aug-06-26ReiteratedMorgan StanleyOverweight$34 → $31
Aug-06-26ReiteratedRobert W. Baird$27 → $25
Aug-06-26ReiteratedMizuho SecuritiesOutperform$37 → $28
Aug-06-26ReiteratedJefferiesBuy$25 → $21
Aug-06-26ReiteratedTruist SecuritiesBuy$35 → $30
Aug-06-26ReiteratedWells FargoOverweight$30 → $29
Aug-06-26DowngradeBenchmarkBuy → Hold
Aug-06-26ReiteratedBTIGBuy$30 → $25
Latest News· Times ET
Oct-27-26
Oct-25-26
Oct-21-26
Oct-20-26
Oct-20-2601:18PM
Oct-16-26
Oct-14-26
Oct-11-26
Oct-05-26
Sep-30-26
Sep-24-26
Sep-18-26
Sep-15-26
Sep-11-26
Sep-10-26
Company

Klaviyo, Inc. is a technology company offering a software-as-a-service (SaaS) platform that empowers its clients to send highly targeted and pertinent messages via email, text message (SMS), and push notifications. The firm's primary product, Klaviyo, is a marketing automation platform engineered for personalized outreach. Its comprehensive suite of solutions includes an email marketing tool that meticulously monitors clicks and purchases to enhance campaign effectiveness; an SMS service crafted for fostering e-commerce expansion and customer loyalty; and a mobile push feature for direct engagement with users through lock screen alerts. Additionally, Klaviyo provides a Review solution to collect product feedback and a robust customer data platform (CDP) designed for efficient storage, analysis, and utilization of large datasets. The company caters to individual users, small and medium-sized businesses, and larger corporations across North America, Western Europe, Canada, the United Kingdom, Australia, and New Zealand. Established in 2012, Klaviyo is headquartered in Boston, Massachusetts.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
Total Revenue1,3901,234937698——
Cost of Goods Sold Incl. D&A363313221178——
Gross Profit1,026921716520——
Selling, General and Administrative Excl. Other730698562589——
Research and Development322291238262——
Other Operating Expense
0000——
Operating Income-26-68-84-331——
Interest Expense
0000——
Unusual Expense
——————
Non-Operating Income (Expense)37374024——
Net Income Before Taxes11-31-44-307——
Income Taxes5121——
Consolidated Net Income7-32-46-308——
Net Income From Continuing Operations7-32-46-308——
Net Income7-32-46-308——
EPS (Recurring)0.02-0.11-0.17-1.27——
EPS (Basic, Before Extraordinaries)0.02-0.11-0.17-1.27——
EPS (Diluted)0.02-0.11-0.17-1.27——
EBITDA34-12-26-293——
Other After Tax Adjustments
——————
Stock Option Compensation Expense
——————
Price To Earnings Ratio
1,090.00—————
Price To Sales Ratio4.667.6611.719.67——
Gross Margin73.8174.6476.4174.50——
Operating Margin-1.87-5.51-8.96-47.42——
Net Margin0.50-2.59-4.91-44.13——
Shares Outstanding297291266243——
Market Capitalization6,4759,44910,9706,751——
Operating Lease Expense
——————
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$39.38$31.88$24.39$16.90$9.40● Close Price0.00M23.02M46.03M69.05M92.07MUSD Trades VolumeNovDec2026FebMarAprMayJunJulAugSepOctNov
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Hallen EdDirector, 10% OwnerOct 07 '26Sale17.4097,4821,696,18755,290Oct 09
Hallen EdDirector, 10% OwnerSep 24 '26Sale17.021,30022,12693,957Sep 25
St. Ledger SusanDirectorSep 11 '26Sale15.932,32837,08523,433Sep 14
Hallen EdDirector, 10% OwnerAug 31 '26Sale20.4898,7822,023,25994,457Sep 01
Edmond LandonChief Legal OfficerAug 31 '26Sale20.448,103165,625477,866Sep 01
Edmond LandonChief Legal OfficerAug 28 '26Sale20.0153,4731,069,995485,969Sep 01
Shopify Strategic Holdings 3 LLC10% OwnerAug 31 '26Option Exercise0.00344,383017,317,491Aug 31
Whalen AmandaChief Financial OfficerAug 14 '26Sale18.4714,000258,580824,192Aug 18
SUMMIT PARTNERS L P10% OwnerAug 11 '26Sale17.715,000,00088,550,0000Aug 13
Whalen AmandaChief Financial OfficerJul 16 '26Sale17.7514,000248,500838,192Jul 17
Whalen AmandaChief Financial OfficerJun 18 '26Sale13.2314,000185,220852,192Jun 18
Bialecki AndrewCo-Chief Executive OfficerMay 26 '26Sale14.61212,5293,105,0490May 28
Bialecki AndrewCo-Chief Executive OfficerMay 19 '26Sale14.88200,0002,976,0000May 20
St. Ledger SusanDirectorMay 18 '26Sale14.279,334133,19610,939May 20
Whalen AmandaChief Financial OfficerMay 14 '26Sale14.2614,000199,640895,141May 18
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.